PH12017500656A1 - Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers - Google Patents
Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiersInfo
- Publication number
- PH12017500656A1 PH12017500656A1 PH12017500656A PH12017500656A PH12017500656A1 PH 12017500656 A1 PH12017500656 A1 PH 12017500656A1 PH 12017500656 A PH12017500656 A PH 12017500656A PH 12017500656 A PH12017500656 A PH 12017500656A PH 12017500656 A1 PH12017500656 A1 PH 12017500656A1
- Authority
- PH
- Philippines
- Prior art keywords
- cyclohexyloxy
- quinoline
- amino
- substituted
- sweet flavor
- Prior art date
Links
- BVWTWXNNNSUWCN-UHFFFAOYSA-N NC1=C(C=NC2=CC=CC(=C12)OC1CCCCC1)C(=O)O Chemical class NC1=C(C=NC2=CC=CC(=C12)OC1CCCCC1)C(=O)O BVWTWXNNNSUWCN-UHFFFAOYSA-N 0.000 title abstract 2
- 235000009508 confectionery Nutrition 0.000 title abstract 2
- 239000000796 flavoring agent Substances 0.000 title abstract 2
- 235000019634 flavors Nutrition 0.000 title abstract 2
- 239000003607 modifier Substances 0.000 title abstract 2
- 239000008122 artificial sweetener Substances 0.000 abstract 1
- 235000021311 artificial sweeteners Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000021096 natural sweeteners Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2054—Heterocyclic compounds having nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
Abstract
Disclosed herein are 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acid compounds having useful as sweet flavor modifiers. Also disclosed herein are ingestible compositions that include one or more of these compounds in combination with a natural or artificial sweetener.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462076975P | 2014-11-07 | 2014-11-07 | |
PCT/US2015/057753 WO2016073251A1 (en) | 2014-11-07 | 2015-10-28 | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12017500656A1 true PH12017500656A1 (en) | 2017-10-02 |
Family
ID=55909633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12017500656A PH12017500656A1 (en) | 2014-11-07 | 2017-04-07 | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
Country Status (7)
Country | Link |
---|---|
US (1) | US11339128B2 (en) |
AU (1) | AU2015343463A1 (en) |
BR (1) | BR112017008738B1 (en) |
CA (1) | CA2963901A1 (en) |
MX (1) | MX2017005931A (en) |
PH (1) | PH12017500656A1 (en) |
WO (1) | WO2016073251A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY190296A (en) | 2015-10-29 | 2022-04-12 | Firmenich Incorporated | High intensity sweeteners |
MX2019012940A (en) | 2017-05-03 | 2019-12-16 | Firmenich Incorporated | Methods for making high intensity sweeteners. |
US11006659B2 (en) | 2017-09-26 | 2021-05-18 | King Saud University | Fortified date fruit product |
JP2020536537A (en) | 2017-10-06 | 2020-12-17 | カーギル インコーポレイテッド | I Ching steviol glycoside composition |
EP3952667A1 (en) | 2019-04-06 | 2022-02-16 | Cargill, Incorporated | Sensory modifiers |
JP2024503099A (en) | 2021-01-15 | 2024-01-24 | フィルメニッヒ インコーポレイテッド | Sweetener compositions containing mogrosides and their uses |
EP4258895A1 (en) | 2021-01-15 | 2023-10-18 | Firmenich Incorporated | Sweetener compostions comprising siamenoside i and uses thereof |
WO2023172415A1 (en) | 2022-03-07 | 2023-09-14 | Firmenich Incorporated | Sweetener compositions |
WO2023169995A1 (en) | 2022-03-10 | 2023-09-14 | Firmenich Sa | Sweetener compositions |
WO2023198436A2 (en) | 2022-04-11 | 2023-10-19 | Firmenich Sa | Sweetener compositions |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2030899A1 (en) | 1970-06-18 | 1971-12-23 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Quinoline carboxylic acid derivatives |
FR2101004B2 (en) | 1970-08-05 | 1974-02-01 | Bellon Labor Sa Roger | |
JPS5833843B2 (en) | 1974-10-24 | 1983-07-22 | 武田薬品工業株式会社 | Suisanyou Yakuzai |
JPS52142098A (en) | 1976-05-20 | 1977-11-26 | Sumitomo Chem Co Ltd | 1-fluoroalkyl-491h)-oxo-3-quinolinecarboxylic acid derivatives |
DE3111155A1 (en) | 1981-03-21 | 1982-09-30 | Troponwerke GmbH & Co KG, 5000 Köln | 5,6-DIMETHYL-PYRROLO (2,3-B) PYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT |
EP0096996B1 (en) | 1982-06-15 | 1988-06-22 | Mobil Oil Corporation | Process for the conversion of alcohols into petrochemicals |
US4552883A (en) | 1982-06-15 | 1985-11-12 | Ici Americas Inc. | Pyrazolo[3,4-b]pyridine carboxylic acid esters and their pharmaceutical use |
GB8600651D0 (en) | 1986-01-11 | 1986-02-19 | Beecham Group Plc | Compounds |
US4952584A (en) | 1986-01-11 | 1990-08-28 | Beecham Group P.L.C. | 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity |
GB8610981D0 (en) | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
GB8804447D0 (en) | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
US5240934A (en) | 1990-10-19 | 1993-08-31 | Ss Pharmaceutical Co., Ltd. | Quinoline derivatives |
GB9125485D0 (en) | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
JPH06199855A (en) | 1992-12-31 | 1994-07-19 | Nippon Nohyaku Co Ltd | Pyrazolopyridine derivative and platelet aggregation inhibitor containing same |
US5776942A (en) | 1994-06-17 | 1998-07-07 | Nippon Zoki Pharmaceutical Co., Ltd. | Bronchodilating pyrido 2,3-d!pyrimidine derivatives |
US5593997A (en) | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
AR016817A1 (en) | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | DERIVATIVES OF FENILUREA OR FENILTIOUREA, PROCEDURE FOR PREPARATION, COLLECTION OF COMPOUNDS, INTERMEDIARY COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
DE19738616A1 (en) | 1997-09-04 | 1999-03-11 | Clariant Gmbh | 4-hydroxyquinoline-3-carboxylic acid derivatives as light stabilizers |
US6077851A (en) | 1998-04-27 | 2000-06-20 | Active Biotech Ab | Quinoline derivatives |
EP1218401B1 (en) | 1999-09-22 | 2004-06-16 | Aventis Pharma Deutschland GmbH | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
TW201022287A (en) | 2001-01-03 | 2010-06-16 | Senomyx Inc | T1R taste receptors and genes encoding same |
US20050119302A1 (en) | 2001-10-30 | 2005-06-02 | Rahme Laurence G. | Methods for the prevention or treament of bacterial and fungal infections |
EP1451156A4 (en) | 2001-11-27 | 2005-05-25 | Merck & Co Inc | 4-aminoquinoline compounds |
AU2003248921A1 (en) | 2002-07-09 | 2004-01-23 | Point Therapeutics, Inc. | Boroproline compound combination therapy |
US20080026077A1 (en) | 2002-11-12 | 2008-01-31 | John Hilfinger | Methods and compositions of gene delivery agents for systemic and local therapy |
NZ545747A (en) | 2003-08-06 | 2010-06-25 | Senomyx Inc | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
EP1720856B1 (en) | 2004-02-11 | 2013-08-14 | GlaxoSmithKline LLC | Hiv integrase inhibitors |
AU2005221208A1 (en) | 2004-03-11 | 2005-09-22 | Neurogen Corporation | Substituted 5,12-diaza-benzoanthracene analogues |
AR049216A1 (en) | 2004-06-09 | 2006-07-05 | Avanir Pharmaceuticals | HETEROCICLIC DERIVATIVES AS MEDIATORS OF INVERSE TRANSPORTATION OF CHOLESTEROL FOR THE TREATMENT OF HYPERLIPIDEMIA AND RELATED CARDIOVASCULAR DISEASES |
CN101006076B (en) | 2004-06-24 | 2010-09-29 | 沃泰克斯药物股份有限公司 | Modulators of ATP-binding cassette transporters |
UY29016A1 (en) | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C |
US20060045953A1 (en) | 2004-08-06 | 2006-03-02 | Catherine Tachdjian | Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers |
GB0425572D0 (en) | 2004-11-19 | 2004-12-22 | Glaxo Group Ltd | 1,7-Naphthyridines |
JP2008524134A (en) | 2004-12-17 | 2008-07-10 | エフ.ホフマン−ラ ロシュ アーゲー | Thieno-pyridine derivatives as GABA-B allosteric enhancers |
GB0505621D0 (en) | 2005-03-18 | 2005-04-27 | Glaxo Group Ltd | Novel compounds |
US7304074B2 (en) | 2005-04-05 | 2007-12-04 | Hoffmann-La Roche Inc. | Substituted 1,5-naphthyridine azolinones |
BRPI0611521A2 (en) | 2005-05-18 | 2010-09-14 | Wyeth Corp | 4,6-diamino- [1,7] naphthyridine-3-carbonitrile kinase tpl2 inhibitors and methods of manufacture and use thereof |
CN101258157A (en) | 2005-05-24 | 2008-09-03 | 阿斯利康(瑞典)有限公司 | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
AR055329A1 (en) | 2005-06-15 | 2007-08-15 | Senomyx Inc | BIS-AROMATIC AMIDAS AND ITS USES AS SWEET FLAVORS, FLAVORS, AND FLAVOR ENHANCERS |
EP2007373A4 (en) | 2006-03-29 | 2012-12-19 | Foldrx Pharmaceuticals Inc | Inhibition of alpha-synuclein toxicity |
DE102006029446A1 (en) | 2006-06-21 | 2007-12-27 | Bayer Schering Pharma Ag | New 3-substituted quinolines as kinase inhibitors |
US7928111B2 (en) | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
US8076491B2 (en) | 2007-08-21 | 2011-12-13 | Senomyx, Inc. | Compounds that inhibit (block) bitter taste in composition and use thereof |
CA2705820C (en) | 2007-11-15 | 2016-06-07 | Clanotech Ab | Quinoline derivatives and their use as tyrosine kinase inhibitors |
CN104193723B (en) | 2008-02-06 | 2019-05-31 | 西诺米克斯公司 | Sweetener compositions and preparation method thereof |
WO2011075559A1 (en) | 2009-12-18 | 2011-06-23 | Glaxo Wellcome Manufacturing Pte Ltd. | Novel compounds |
JP5988506B2 (en) | 2010-04-02 | 2016-09-07 | セノミックス インコーポレイテッド | Sweetness modifier |
WO2012021837A2 (en) * | 2010-08-12 | 2012-02-16 | Senomyx, Inc. | Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer |
AU2012295255B2 (en) | 2011-08-12 | 2016-04-21 | Senomyx, Inc. | Sweet flavor modifier |
WO2013158929A1 (en) | 2012-04-18 | 2013-10-24 | Nitto Denko Corporation | Phosphor ceramics and methods of making the same |
WO2013158928A2 (en) * | 2012-04-18 | 2013-10-24 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
US20140272068A1 (en) * | 2013-03-14 | 2014-09-18 | Indra Prakash | Beverages containing rare sugars |
-
2015
- 2015-10-28 CA CA2963901A patent/CA2963901A1/en not_active Abandoned
- 2015-10-28 WO PCT/US2015/057753 patent/WO2016073251A1/en active Application Filing
- 2015-10-28 US US14/925,793 patent/US11339128B2/en active Active
- 2015-10-28 AU AU2015343463A patent/AU2015343463A1/en not_active Abandoned
- 2015-10-28 MX MX2017005931A patent/MX2017005931A/en unknown
- 2015-10-28 BR BR112017008738-3A patent/BR112017008738B1/en active IP Right Grant
-
2017
- 2017-04-07 PH PH12017500656A patent/PH12017500656A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2015343463A1 (en) | 2017-06-15 |
CA2963901A1 (en) | 2016-05-12 |
US20160185727A1 (en) | 2016-06-30 |
US11339128B2 (en) | 2022-05-24 |
WO2016073251A1 (en) | 2016-05-12 |
BR112017008738A2 (en) | 2017-12-19 |
BR112017008738B1 (en) | 2021-06-15 |
MX2017005931A (en) | 2017-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500656A1 (en) | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers | |
PH12017501956A1 (en) | Compositions of obeticholic acid and methods of use | |
PH12017501033A1 (en) | Oral care compositions and methods of use | |
PH12017501310A1 (en) | Oral care compositions and methods of use | |
EP3261626A4 (en) | Methods and compositions relating to biocompatible implants | |
EP3232817A4 (en) | Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility | |
EA201691911A1 (en) | QUICKLY COMPOSITION INSULIN | |
EP3146039A4 (en) | Micronized wharton's jelly | |
JO3155B1 (en) | Sweet flavor modifier | |
EP3167049A4 (en) | Micronized wharton's jelly | |
EP3142695A4 (en) | Compositions and methods of enhancing immunogenicity of polysaccharide-protein conjugates | |
EP3452494A4 (en) | Compositions and methods related to hiv-1 immunogens | |
MX2017002803A (en) | Attenuated bovine coronavirus and related vaccines. | |
MX2013002948A (en) | Pharmaceutical and nutraceutical compositions of abscisic acid. | |
EP3148500A4 (en) | Oral care compositions having improved stability | |
EP3223809A4 (en) | Amino acid compositions for the treatment of symptoms of disease | |
MX2017016588A (en) | Novel triterpene-glycosides as sweeteners or sweetener enhancer. | |
MY181656A (en) | Glue composition | |
EP3176173A4 (en) | Crystalline free bases of c-met inhibitor or crystalline acid salts thereof, and preparation methods and uses thereof | |
EP3139741A4 (en) | Methods and compositions comprising 10-hydroxy-2-decenoic acid | |
EP3148517A4 (en) | Compositions and methods to promote bone formation | |
PH12016501326A1 (en) | (s)-3'-methyl-abscisic acid and esters thereof | |
IL258258B (en) | Lipoic acid choline ester compositions and methods to generate biocompatible ophthalmic formulations | |
EP3165599A4 (en) | Novel lactic acid bacterium and composition including said lactic acid bacterium | |
IL259073A (en) | 3'-substituted-abscisic acid derivatives |